Delivery of peptides and proteins through the blood-brain barrier

Advanced Drug Delivery Reviews

Volumn 46, Issue 1-3, 2001, Pages 247-279

  Bickel, Ulrich ^a   Yoshikawa, Takayoshi ^a   Pardridge, William M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Avidin; Biotin; Cationized albumin; CD4; Drug delivery; Monoclonal antibody; Opioid peptides; Transferrin; VIP

Indexed keywords

PEPTIDE; PROTEIN;

ANIMAL; BLOOD BRAIN BARRIER; CHEMISTRY; DRUG DELIVERY SYSTEM; HUMAN; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; REVIEW;

ADMINISTRATION, ORAL; ANIMALS; BLOOD-BRAIN BARRIER; DRUG DELIVERY SYSTEMS; HUMANS; PEPTIDES; PROTEINS;

EID: 0035292828     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(00)00139-3     Document Type: Article

References (141)

1. L.E. De Bault, P.A. Cancilla, Gamma-glutamyl transpeptidase in isolated brain endothelial cells: Induction by glial cells in vitro, Science 207 (1980) 653-655.
2. C. Cordon-Cardo, J.P. O'Brien, D. Casals, L. Rittman-Grauer, J.L. Biedler, M.R. Melamed, J.R. Bertino, Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites, Proc. Natl. Acad. Sci. USA 86 (1989) 695-698.
3. M. Mueckler, C. Caruso, S.A. Baldwin, M. Panico, I. Blench, H.R. Morris, W.J. Allard, G.E. Lienhard, H.F. Lodish, Sequence and structure of a human glucose transporter, Science 229 (1985) 941-945.
4. M.J. Birnbaum, H.C. Haspel, O.M. Rosen, Cloning and characterization of a cDNA encoding the rat brain glucose-transporter protein, Proc. Natl. Acad. Sci. USA 83 (1986) 5784-5788.
5. W.M. Pardridge, R.J. Boado, C.R. Farrell, Brain-type glucose transporter (GLUT1) is selectively localized to the blood-brain barrier. Studies with quantitative Western blotting and in situ hybridization, J. Biol. Chem. 265 (1990) 18035-18040.
6. W.M. Pardridge, D. Triguero, J. Yang, RA. Cancilla, Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier, J. Pharmacol. Exp. Ther. 253 (1990) 884-891.
7. H. Duvernoy, S. Delon, J.L. Vannson, The vascularization of the human cerebellar cortex, Brain Res. Bull. 11 (1983) 419-480.
8. M.W. Brightman, Morphology of blood-brain interfaces, Exp. Eye Res. 25 (1977) 1-25.
9. A. Weindl, Neuroendocrine aspects of circumventricular organs, in: W.F. Ganong, L. Martini (Eds.), Frontiers in Neuroendocrinology, Oxford University Press, New York, 1973, pp. 3-32.
10. C. Crone, The blood-brain barrier- facts and questions, in: B.K. Siesjo, S.C. Sorensen (Eds.), Ion Homeostasis of the Brain, Munksgaard, Copenhagen, 1971, pp. 52-62.
11. R.A. Fishman, Cerebrospinal Fluid in Diseases of the Nervous System, W.B. Saunders Company, Philadelphia, 1980.
12. H. Davson, K. Welch, M.B. Segal, Secretion of the cerebrospinal fluid, in: The Physiology and Pathophysiology of the Cerebrospinal Fluid, Churchill Livingstone, London, 1987, p. 201.
13. W.R. Shapiro, D.F. Young, B.M. Mehta, Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections, N. Engl. J. Med. 293 (1975) 161-166.
14. R.G. Blasberg, C. Patlak, J.D. Fenstermacher, Intrathecal chemotherapy: brain tissue profiles after ventriculo-cisternal perfusion, J. Pharmacol. Exp. Ther. 195 (1975) 73-83.
15. R.E. Harbaugh, Nerve growth factor as a potential treatment in Alzheimer's disease, Biomed. Pharmacother. 43 (1989) 483-485.
16. T.L. Munsat, J. Taft, I.M.D. Jackson, P.L. Andres, D. Hollander, L. Skerry, M. Ordman, D. Kasdon, L. Finison, Intrathecal thyrotropin releasing hormone does not alter the progressive course of ALS, Neurology 42 (1992) 1049-1053.
17. J.T. Caroscio, J.A. Cohen, J. Zawodniak, V. Takai, A. Shapiro, S. Blaustein, M.N. Mulvihill, S.P. Loucas, M. Gudesblatt, D. Rube, M.D. Yahr, A double-blind, placebo-controlled trial of TRH in amyotrophic lateral sclerosis, Neurology 36 (1986) 141-145.
18. R.E. Rieselbach, G. Di Chiro, E.J. Freireich, D.P. Rall, Subarachnoid distribution of drugs after lumbar injection, N. Engl. J. Med. 267 (1962) 1273-1278.
19. W.H. Oldendorf, Measurement of brain uptake of radio-labeled substances using a tritiated water internal standard, Brain Res. 24 (1970) 372.
20. W.M. Pardridge, Recent advances in blood-brain barrier transport, Annu. Rev. Pharmacol. Toxicol. 28 (1988) 25-39.
21. W.M. Pardridge, E. Landaw, Tracer kinetic model of blood-brain barrier transport of plasma protein-bound ligands, J. Clin. Invest. 74 (1984) 745-752.
22. B.V. Zlokovic, D.J. Begley, B.M. Djuricic, D.M. Mitrovic, Measurement of solute transport across the blood-brain barrier in the perfused guinea pig brain: Method and application to N-methyl-α-aminoisobutyric acid, J. Neurochem. 46 (1986) 1444-1451.
23. B.V. Zlokovic, M.N. Lipovac, D.J. Begley, H. Davson, L. Rakic, Transport of leucine-enkephalin across the blood-brain barrier in the perfused guinea pig brain, J. Neurochem. 49 (1987) 310-315.
24. B.V. Zlokovic, M.N. Lipovac, D.J. Begley, H. Davson, L. Rakic, Slow penetration of thyrotropin-releasing hormone across the blood-brain barrier of an in situ perfused guinea pig brain, J. Neurochem. 51 (1988) 252-257.
25. B.V. Zlokovic, J.B. Mackic, B. Djuricic, H. Davson, Kinetic analysis of leucine-enkephalin cellular uptake at the luminal side of the blood-brain barrier of an in situ perfused guinea-pig brain, J. Neurochem. 53 (1989) 1333-1340.
26. Y. Takasato, S.I. Rapoport, Q.R. Smith, An in situ brain perfusion technique to study cerebrovascular transport in the rat, Am. J. Physiol. 247 (1984) H484-H493.
27. J.D. Fenstermacher, R.J. Blasberg, C.L. Patlak, Methods for quantifying the transport of drugs across brain barrier systems, Pharmacol. Ther. 14 (1981) 217-248.
28. C.L. Patlak, R.J. Blasberg, J.D. Fenstermacher, Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data, J. Cereb. Blood Flow Metab. 3 (1983) 1-7.
29. R.J. Blasberg, J.D. Fenstermacher, C.L. Patlak, Transport of α-aminoisobutyric acid across brain capillary and cellular membranes, J. Cereb. Blood Flow Metab. 3 (1983) 8-32.
30. W.M. Pardridge, D. Triguero, J.L. Buciak, β-endorphin chimeric peptides: Transport through the blood-brain barrier in vivo and cleavage of disulfide linkage by brain, Endocrinology 126 (1990) 977-984.
31. L. Churchill, H.H. Bausback, M.E. Gerritsen, P.E. Ward, Metabolism of opioid peptides by cerebral microvascular aminopeptidase M, Biochim. Biophys. Acta 923 (1987) 35-41.
32. B. Solhonne, C. Gros, H. Pollard, J.-C. Schwartz, Major localization of aminopeptidase M in rat brain microvessels, Neuroscience 22 (1987) 225-232.
33. 5-enkephalin and their N-terminal amino acid (tyrosine), Brain Res. 336 (1985) 125.
34. D. Triguero, J.B. Buciak, W.M. Pardridge, Capillary depletion method for quantifying blood-brain barrier transcytosis of circulating peptides and plasma proteins, J. Neurochem. 54 (1990) 1882-1888.
35. K.R. Duffy, W.M. Pardridge, Blood-brain barrier transcytosis of insulin in developing rabbits, Brain Res. 420 (1987) 32-38.
36. R.D. Broadwell, B.J. Balin, M. Salcman, Transcytotic pathway for blood-borne protein through the blood-brain barrier, Proc. Natl. Acad. Sci. USA 85 (1988) 632-636.
37. F. Joo, The blood-brain barrier in vitro: Ten years of research on microvessels isolated from the brain, Neurochem. Int. 7 (1985) 1-25.
38. R. Lasbennes, J. Gayet, Capacity for energy metabolism in microvessels isolated from rat brain, Neurochem. Res. 9 (1983) 1-9.
39. W.M. Pardridge, Peptide Drug Delivery To the Brain, Raven Press, New York, 1991.
40. M. van Houten, B.I. Posner, B.M. Kopriwa, J.R. Brawer, Insulin-binding sites in the rat brain: In vivo localization to the circumventricular organs by quantitative radioautography, Endocrinology 105 (1979) 666-673.
41. H.J.L. Frank, W.M. Pardridge, A direct in vitro demonstration of insulin binding to isolated brain microvessels, Diabetes 30 (1981) 757-761.
42. W.M. Pardridge, J. Eisenberg, J. Yang, Human blood-brain barrier insulin receptor, J. Neurochem. 44 (1985) 1771-1778.
43. K.R. Duffy, W.M. Pardridge, R.G. Rosenfeld, Human blood-brain barrier insulin-like growth factor receptor, Metabolism 37 (1988) 136-140.
44. H.J.L. Frank, W.M. Pardridge, W.L. Morris, R.G. Rosenfeld, T.B. Choi, Binding and internalization of insulin and insulin-like growth factors by isolated brain microvessels, Diabetes 35 (1986) 654-661.
45. R.C. Speth, S.J. Harik, Angiotensin II receptor binding sites in brain microvessels, Proc. Natl. Acad. Sci. USA 82 (1985) 6340-6343.
46. P.E. Chabrier, P. Roubert, P. Braquet, Specific binding of atrial natriuretic factor in brain microvessels, Proc. Natl. Acad. Sci. USA 84 (1987) 2078-2081.
47. M. Okazaki, K. Kobayashi, A. Kuroiwa, F. Tsumi, Atrial natriuretic peptide receptors in cerebral microvessels and choroid plexus of spontaneously hypertensive rats, Brain Res. 518 (1990) 292-294.
48. R.A. Jefland, H.J.L. Frank, E. Levin, A. Pednaum, Brain and atrial natriuretic peptide bind to common receptors in brain capillary endothelial cells, Am. J. Physiol. 261 (1991) E183-E189.
49. M. Hashimoto, Y. Ishikawa, L. Yokota, F. Soto, T. Bando, Y. Sakakibara, M. Iziki, Action site of circulating interleukin-1 on the rabbit brain, Brain Res. 540 (1991) 217-223.
50. W.A. Banks, L. Ortiz, S.R. Plotkin, A.J. Kastin, Human interleukin (IL) 1α murine IL-1β and murine IL-1β are transported from blood to brain in the mouse by a shared saturable mechanism, J. Pharmacol. Exp. Ther. 259 (1991) 988-996.
51. W.A. Jefferies, M.R. Brandon, S.V. Hunt, A.F. Williams, K.C. Gatter, D.Y. Mason, Transferrin receptor on endothelium of brain capillaries, Nature 312 (1984) 162-163.
52. J.B. Fishman, J.B. Rubin, J.V. Handrahan, J.R. Connor, R.E. Fine, Receptor-mediated transcytosis of transferrin across the blood-brain barrier, J. Neurosci. Res. 18 (1987) 299-304.
53. F.M. Taylor, E.H. Morgan, Developmental changes in transferrin and iron uptake by the brain in the rat, Dev. Brain Res. 55 (1990) 35-42.
54. P. Grasso, B. Dattatreyamurty, J.A. Dias, L.E. Reichert Jr., Transglutaminase activity in bovine calf testicular membranes: Evidence for a possible role in the interaction of follicle-stimulating hormone with its receptor, Endocrinology 121 (1987) 459-465.
55. M. Gex-Fabry, C. DeLisi, Receptor-mediated endocytosis: A model and its implications for experimental analysis, Am. J. Physiol. 247 (1984) R768-R779.
56. K. Verner, G. Schatz, Protein translocation across membranes, Science 241 (1988) 1307-1313.
57. K.A. Lund, L.K. Opresko, C. Starbuck, B.J. Walsh, H.S. Wiley, Quantitative analysis of the endocytic system involved in hormone-induced receptor internalization, J. Biol. Chem. 265 (1990) 15713-15723.
58. B.L. Clarke, RH. Weigel, Recycling of the asialoglycoprotein receptor in isolated rat hepatocytes, J. Biol. Chem. 260 (1985) 128-133.
59. H.J. Solenski, S.K. Williams, Insulin binding and vesicular ingestion in capillary endothelium, J. Cell. Physiol. 124 (1985) 87-95.
60. M.C. Willingham, J.A. Hanover, R.B. Dickson, I. Pastan, Morphologic characterization of the pathway of transferrin endocytosis and recycling in human KB cells, Proc. Natl. Acad. Sci. USA 81 (1984) 175-179.
61. G. Ahnert-Hilger, S. Bhakdi, M. Gratzl, Minimal requirements for exocytosis, J. Biol. Chem. 260 (1985) 12730-12734.
62. D.D. McAbee, RH. Weigel, ATP depletion causes a reversible redistribution and inactivation of a subpopulation of galactosyl receptors in isolated rat hepatocytes, J. Biol. Chem. 260 (1987) 128-133.
63. J. Vilmart-Seuwen, H. Kersken, R. Sturzl, H. Plattner, ATP keeps exocytosis sites in a primed state but is not required for membrane fusion: An analysis with Paramecium cells in vivo and in vitro, J. Cell Biol. 103 (1986) 1279-1288.
64. W. Almers, Exocytosis, Annu. Rev. Physiol. 52 (1990) 607-624.
65. W.M. Pardridge, J. Yang, J. Eisenberg, Blood-brain barrier protein phosphorylation and dephosphorylation, J. Neurochem. 45 (1985) 1141-1147.
66. N.K. Gonatas, A. Stieber, W.F. Mickey, S.H. Herbert, J.O. Gonatas, Endosomes and Golgi vesicles in adsorptive and fluid phase endocytosis, J. Cell Biol. 99 (1984) 1379-1390.
67. A. Nevo, A. De Vries, A. Katchalsky, Interaction of basic polyamino acids with the red blood cell, Biochim. Biophys. Acta 17 (1955) 536-547.
68. E. Skutelsky, D. Danon, Redistribution of surface anionic sites on the luminal front of blood vessel endothelium after interaction with polycationic ligand, J. Cell. Biol. 71 (1976) 232-241.
69. A.W. Vorbrodt, Ultracytochemical characterization of anionic sites in the wall of brain capillaries, J. Neurocytol. 18 (1989) 359-368.
70. S.K. Basu, J.L. Goldstein, R.G.W. Anderson, M.S. Brown, Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts, Proc. Natl. Acad. Sci. USA 73 (1976) 3178-3182.
71. W.-C. Shen, H.J.-P. Ryser, Conjugation of poly-L-lysine to albumin and horseradish peroxidase: A novel method of enhancing the cellular uptake of proteins, Proc. Natl. Acad. Sci. USA 75 (1978) 1872-1876.
72. D.E. Griffin, J. Giffels, Study of protein characteristics that influence entry into the cerebrospinal fluid of normal mice and mice with encephalitis, J. Clin. Invest. 70 (1982) 289-295.
73. T. Terasaki, S. Ken-Ichihirai Hitoshi, Y.S. Kang, A. Tsuji, Absorptive-mediated endocytosis of a dynorphin-like analgesic peptide, e-2078, into the blood-brain barrier, J. Pharmacol. Exp. Ther 251 (1989) 351-357.
74. T. Terasaki, Y. Deguchi, H. Sato, K. Hirai, A. Tsuij, In vivo transport of a dynorphin-like analgesic peptide, E-2078, through the blood-brain barrier: An application of brain microdialysis, Pharm. Res. 8 (1991) 815-820.
75. T. Shimura, S. Tabata, T. Ohnishi, T. Terasaki, A. Tsuji, Transport mechanism of a new behaviorally highly potent adrenocorticotropic hormone (ACTH) analog, ebiratide, through the blood brain barrier, J. Pharmacol. Exp. Ther. 258 (1991) 459-465.
76. T. Peters Jr., Serum albumin. Adv. Protein Chem. 17 (1985) 161-245.
77. P.P. Lambert, M. Doriaux, J. Sennesael, R. Vanholder, M. Lammens-Verslijpe, The pathogenicity of cationized albumin in the dog, in: P.P. Lambert, P. Bergmann, R. Beauwens (Eds.), The Pathogenicity of Cationic Proteins, Raven Press, New York, 1983, pp. 307-317.
78. A.K. Kumagai, J. Eisenberg, W.M. Pardridge, Absorptive-mediated endocytosis of cationized albumin and a β-endorphin-cationized albumin chimeric peptide by isolated brain capillaries. Model system of blood-brain barrier transport, J. Biol. Chem. 262 (1987) 15214-15219.
79. W.M. Pardridge, D. Triguero, J.L. Buciak, J. Yang, Evaluation of cationized rat albumin as a potential blood-brain barrier drug transport vector, J. Pharmacol. Exp. Ther. 255 (1990) 893-899.
80. P. Bergmann, R. Kacenelenbogen, A. Vizet, Plasma clearance, tissue distribution and catabolism of cationized albumins with increasing isoelectric points in the rat, Clin. Sci. 67 (1984) 35-43.
81. W.M. Pardridge, D. Triguero, J.B. Buciak, Transport of histone through the blood-brain barrier, J. Pharmacol. Exp. Ther. 251 (1989) 821-826.
82. J.E. Hardebo, J. Kahrstrom, Endothelial negative surface charge areas and blood-brain barrier function, Acta Physiol. Scand. 125 (1985) 495-499.
83. Z. Nagy, H. Peters, I. Huttner, Charge-related alterations of the cerebral endothelium, Lab. Invest. 49 (1983) 662-671.
84. L.J. Strausbaugh, Intracarotid infusions of protamine sulfate disrupt the blood-brain barrier of rabbits, Brain Res. 409 (1987) 221-226.
85. V.M. Vehaskari, T.-C. Chang, J.K. Stevens, A.M. Robson, The effects of polycations on vascular permeability in the rat, J. Clin. Invest. 73 (1984) 1053-1061.
86. S.G. Adler, H. Wang, H.J. Ward, A.H. Cohen, W.A. Border, Electrical charge. Its role in the pathogenesis and prevention of experimental membranous nephropathy in the rabbit, J. Clin. Invest. 71 (1983) 487-499.
87. J.T. Huang, M. Mannik, J. Gleisner, In situ formation of immune complexes in the choroid plexus of rats by sequential injection of a cationized antigen and unaltered antibodies, J. Neuropathol. Exp. Neurol. 43 (1984) 489-499.
88. L.J. Nell, J.W. Thomas, Frequency and specificity of protamine antibodies in diabetic and control subjects, Diabetes 37 (1988) 172-176.
89. A. Muckerheide, R.J. Apple, A.J. Pesce, J.G. Michael, Cationization of protein antigens, J. Immunol. 138 (1987) 833-837.
90. D. Triguero, J.B. Buciak, J. Yang, WM. Pardridge, Blood-brain barrier transport of cationized immunoglobulin G. Enhanced delivery compared to native protein, Proc. Natl. Acad. Sci. USA 86 (1989) 4761-4765.
91. W.M. Pardridge, J. Eisenberg, W.T. Cefalu, Absence of albumin receptor on brain capillaries in vivo or in vitro, Am. J. Physiol. 249 (1985) E264-E267.
92. D. Triguero, J.L. Buciak, WM. Pardridge, Cationization of immunoglobulin G results in enhanced organ uptake of the protein following intravenous administration in rats and primate, J. Pharmacol. Exp. Ther. 258 (1991) 186-192.
93. P. Bergmann, A. Vizet, J. Sennesael, R. Beauwens, J. Snauwert, Binding of cationized albumin to red cells, in: P.P. Lambert, P. Bergmann, R. Beauwens (Eds.), The Pathogenicity of Cationic Proteins, Raven Press, New York, 1983, pp. 29-40.
94. V.J. Gauthier, M. Mannik, G.E. Striker, Effect of cationized antibodies in preformed immune complexes on deposition and persistence in renal glomeruli, J. Exp. Med. 156 (1982) 766-777.
95. S. Fujii, T. Nishiura, A. Nishikawa, R. Miura, N. Taniguchi, Structural heterogeneity of sugar chains in immunoglobulin G, J. Biol. Chem. 265 (1990) 6009-6018.
96. J.D. Rodwell, V.L. Alvarez, C. Lee, A.D. Lopes, J.W.F. Goers, H.D. King, H.J. Powsner, T.J. McKearn, Site-specific covalent modification of monoclonal antibodies: In vitro and in vivo evaluations, Proc. Natl. Acad. Sci. USA 83 (1986) 2632-2636.
97. S.L. Morrison, S. Canfield, S. Porter, L.K. Tan, M.-H. Tao, L.A. Wims, Production and characterization of genetically engineered antibody molecules, Clin. Chem. 34 (1988) 1668-1675.
98. S.L. Morrison, M.J. Johnson, L.A. Herzenberg, V.T. Oi, Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains, Proc. Natl. Acad. Sci. USA 81 (1984) 6851-6855.
99. P.W. Mathieson, S.P. Cobbold, G. Hale, M.R. Clark, C.M. Lockwood, H. Waldmann, Monoclonal-antibody therapy in systemic vasculitis, N. Engl. J. Med. 323 (1990) 250-254.
100. A. Abuchowski, T. van Es, N.C. Palczuk, F.F. Davis, Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol, J. Biol. Chem. 252 (1977) 3578-3581.
101. A. Abuchowski, T. van Es, N.C. Palczuk, F.F. Davis, Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase, J. Biol. Chem. 252 (1977) 3582-3586.
102. R. Pool, 'Hairy enzymes' stay in blood, Science 248 (1990) 305.
103. S.J. Giddings, J. Chirgwin, M.A. Permutt, Evaluation of rat insulin messenger RNA in pancreatic and extrapancreatic tissues, Diabetologia 28 (1985) 343-347.
104. D.G. Baskin, D. Porte, K. Guest et al., Regional concentrations of insulin in rat brain, Endocrinology 112 (1983) 898-903.
105. H.J.L. Frank, T. Jankovic-Vokes, W.M. Pardridge, W.L. Morris, Enhanced insulin binding to blood-brain barrier in vivo and to brain microvessels in vitro in newborn rabbits, Diabetes 34 (1985) 728-733.
106. J. Havrankova, J. Roth, M.J. Brownstein, Concentrations of insulin and of insulin receptors in the brain are independent of peripheral insulin levels. Studies of obese and streptozotocin-treated rodents, J. Clin. Invest. 64 (1979) 636-642.
107. H.J.L. Frank, W.M. Pardridge, T. Jankovic-Vokes, H.V. Vinters, W.L. Morris, Insulin binding to the blood-brain barrier in the streptozotocin diabetic rat, J. Neurochem. 47 (1986) 405-411.
108. N.M. Dahms, P. Lobel, S. Kornfeld, Mannose-6-phosphate receptors and lysosomal enzyme targeting, J. Biol. Chem. 264 (1989) 12115-12118.
109. R.G. Rosenfeld, H. Pham, B. Keller, R.T. Borchadt, W.M. Pardridge, Demonstration and structural comparison of receptors for insulin-like growth factor-I and-II (IGF-I and-II) in brain and blood-brain barrier, Biochem. Biophys. Res. Commun. 149 (1987) 159-166.
110. T. Braulke, S. Tippmer, H.-J. Chao, K. von Figura, Insulin-like growth factors I and II stimulate endocytosis but do not affect sorting of lysosomal enzymes in human fibroblasts, J. Biol. Chem. 265 (1990) 6650-6655.
111. K.S. Kovacina, G. Steele-Perkins, A.F. Purchio, M. Lioubin, K. Miyazono, C.H. Heldin, R.A. Roth, Interactions of recombinant and platelet transforming growth factor-beta 1 precursor with the insulin-like growth factor II/mannose 6-phosphate receptor, Biochem. Biophys. Res. Commun. 160 (1989) 393-403.
112. G.A. Werther, M. Abate, A. Hogg, H. Cheesman, B. Oldfield, D. Hards, P. Hudson, B. Power, K. Freed, A.C. Herington, Localization of insulin-like growth factor-I mRNA in rat brain by in situ hybridization-relationship to IGF-I receptors, Molec. Endocrinol. 4 (1990) 773-778.
113. G.K. Haselbacher, M.E. Schwab, A. Pasi, R.E. Humbel, Insulin-like growth factor II (IGF II) in human brain: Regional distribution of IGF II and of higher molecular mass forms, Proc. Natl. Acad. Sci. USA 82 (1985) 2153-2157.
114. I. Ocrant, C.T. Fay, J.T. Parmelee, Characterization of insulin-like growth factor binding proteins produced in the rat central nervous system, Endocrinology 127 (1990) 1260-1267.
115. M.A. Cascieri, R. Saperstein, N.S. Hayes, B.G. Green, G.G. Chiochi, J. Applebaum, M.L. Bayne, Serum half-life and biological activity of mutants of human insulin-like growth factor I which do not bind to serum binding proteins, Endocrinology 123 (1988) 373-381.
116. D.R. Clemmons, M.A. Cascieri, C. Camacho-Hubner, R.H. McCusker, M.L. Bayne, Discrete alterations of the insulin-like growth factor I molecule which alter its affinity for insulin-like growth factor-binding proteins result in changes in bioactivity, J. Biol. Chem. 265 (1990) 12210-12216.
117. M.A. DeVroede, M.M. Rechler, S.P. Nissley, S. Joshi, G.T. Burke, P.G. Katsoyannis, Hybrid molecules containing the B-domain of insulin-like growth factor I are recognized by carrier proteins of the growth factor, Proc. Natl. Acad. Sci. USA 82 (1985) 3010-3014.
118. H.A. Huebers, C.A. Finch, The physiology of transferrin and transferrin receptors, Physiol. Rev. 67 (1987) 520-582.
119. S. Jing, I.S. Trowbridge, Nonacylated human transferrin receptors are rapidly internalized and mediate iron uptake, J. Biol. Chem. 265 (1990) 11555-11559.
120. E. Alvarez, R.J. Girones Davis, Inhibition of the receptor-mediated endocytosis of diferric transferrin is associated with the covalent modification of the transferrin receptor with palmitic acid, J. Biol. Chem. 265 (1990) 16644-16655.
121. W.M. Pardridge, J. Eisenberg, J. Yang, Human blood-brain barrier transferrin receptor, Metabolism 36 (1987) 892-895.
122. P. Seligman, Structure and function of the transferrin receptor, Prog. Hematol. 13 (1983) 131-147.
123. P.M. Friden, L. Walus, G.F. Musso, M.A. Taylor, B. Malfroy, R.M. Starzyk, Antitransferrin receptor antibody and antibody-drug conjugates cross the blood-brain barrier, Proc. Natl. Acad. Sci. USA 88 (1991) 4771-4775.
124. W.M. Pardridge, J.L. Buciak, P. Friden, Selective transport of an anti-transferrin receptor antibody through the blood-brain barrier in vivo, J. Pharmacol. Exp. Ther. 259 (1991) 66-70.
125. N.L. Letvin, VJ. Goldmacher, J. Ritz, J.M. Yetz, S.F. Schlossman, J.M. Lambert, In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates, J. Clin. Invest 77 (1986) 977-984.
126. N.R. Worrell, A.J. Cumber, G.D. Parnell, W.C.J. Ross, J.A. Forrester, Fate of an antibody-ricin A chain conjugate administered to normal rats, Biochem. Pharmacol. 35 (1986) 417-423.
127. W.M. Pardridge, C.L. Farrell, Localization of blood-brain barrier-specific antibodies with immunogold-silver enhancement methodology, J. Histotechnol. (1993), in press.
128. R.D. Broadwell, Transcytosis of macromolecules through the blood-brain barrier: A cell biological perspective and critical appraisal, Acta Neuropathol. 79 (1989) 117-128.
129. W.M. Pardridge, J. Buciak, T. Yoshikawa, Transport of recombinant CD4 through the rat blood brain barrier, J. Pharmacol. Exp. Ther. 261 (1992) 1175-1180.
130. W.M. Pardridge, A.K. Kumagai, J.B. Eisenberg, Chimeric peptides as a vehicle for peptide pharmaceutical delivery through the blood-brain barrier, Biochem. Biophys. Res. Commun. 146 (1987) 307-315.
131. T. Yoshikawa, W.M. Pardridge, Biotin delivery to brain with a covalent conjugate of avidin and a monoclonal antibody to the transferrin receptor, J. Pharmacol. Exp. Ther. 263 (1992) 897-903.
132. W.M. Pardridge, R.J. Boado, J.L. Buciak, Drug delivery of antisense oligonucleotides or peptides to tissues in vivo using an avidin-biotin system, Drug Targeting Delivery (1993), in press.
133. N.M. Green, Avidin and streptavidin, Methods Enzymol. 184 (1990) 51-67.
134. W.M. Pardridge, R.J. Boado, Enhanced cellular uptake of biotinylated antisense oligonucleotide or peptide mediated by avidin, a cationic protein, FEBS Lett. 288 (1991) 30-32.
135. P.W. Riddles, R.L. Blakeley, B. Zernier, Ellman's reagent: 5,5′-dithiobis(2-nitrobenzoic acid)- a reexamination, Anal. Biochem. 94 (1979) 75-81.
136. T.A. Bewley, C.H. Li, Evidence for tertiary structure in aqueous solutions of human β-endorphin as shown by difference absorption spectroscopy, Biochemistry 22 (1983) 2671-2675.
137. T.L. Yaksh, J.-Y. Wang, V.L.W. Go, Cortical vasodilatation produced by vasoactive intestinal polypeptide (VIP) and by physiological stimuli in the cat, J. Gereb. Blood Flow Metab. 7 (1987) 315-326.
138. J. McCulloch, L. Edvinsson, Cerebral circulatory and metabolic effects of vasoactive intestinal polypeptide, Am. J. Physiol. 238 (1980) H449-H456.
139. U. Bickel, T. Yoshikawa, E.M. Landaw, K.F. Faull, WM. Pardridge, Pharmacologic effects in vivo in brain by vector-mediated delivery of peptides, Proc. Natl. Acad. Sci. USA 90 (1993) 2618-2622.
140. M. Andersson, J.-C. Marie, M. Carlquist, V Mutt, The preparation of biotinyl-ε-aminocaproylated forms of the vasoactive intestinal polypeptide (VIP) as probes for the VIP receptor, FEBS Lett. 282 (1991) 35-40.
141. L. Huffman, G.A. Hedge, Effects of vasoactive intestinal peptide on thyroid blood flow and circulating thyroid hormone levels in the rat, Endocrinology 118 (1986) 550-557.